YIM Programme
PRES CONGRESS Login users
 |
 |
 |
|
Wednesday 8th September 2010 Real Club Náutico de Dénia (Alicante, Spain) Wednesday 8th September 2010 www.cndenia.es/club-nautico/situacion_plano.html
List of seniors participants at the YIM Meeting 2010
YIM MEETING 2010 PROGRAMME
8:30 – 9:00: Welcome reception and Presentation
9:00 – 10:30: Session 1: Basic Science in Pediatric Rheumatology 1 Co-chair: Lucy Wedderburn Joost F Swart
YIM.O.1. New genetic variations in the PSTPIP1 gene leading to autoinflammation distinct from classical PAPA syndrome Holzinger D, Lohse P, Fessatou S, Isidor B, Knudsen PK, Sampson B, Koichi I, Ehrchen J, Wittkowski H, Sunderkötter C, Roth J. Münster, Germany
YIM.O.2. Rheumatoid Arthritis susceptibility loci; PTPRC, PTPN2, IKZF3, c5orf30, BLK and CD247 are also associated with Juvenile Idiopathic Arthritis Hinks A, Eyre S, Martin P, Flynn E, Packham J, childhood arthritis prospective study (CAPS), UKRAG Consortium, BSPAR study group, Barton A, Worthington J, Thomson W. Manchester.
YIM.O.3. A novel defect: CD39+ T cells are enriched in the inflamed joint but do not suppress Moncrieffe H, Nistala K, Eaton S, Wedderburn L R. London.
YIM.O.4. Anti-TNFalpha therapy in juvenile idiopathic arthritis primarily affects effector T cells instead of regulatory T cells. Vastert SJ, De Jager W, Wehrens E, Verweij FJ, Klein MR, Kuis W, Van Wijk F, Prakken BJ.
YIM.O.5. Subtype specific association of IL23R with juvenile psoriatic arthritis and erap1 with enthesitis related arthritis (ERA) Hinks A, Martin P, Flynn E, Eyre S, Packham J, childhood arthritis prospective study (CAPS), UKRAG Consortium, BSPAR study group, Barton A, Worthington J, Thomson W. Manchester.
YIM.O.6. Methotrexate does not exert immunomodulatory effects on regulatory t cells but on effector T cells Bulatović M, Vastert S, de Jager W, Verweij F, van Wijk F, Wulffraat N, Prakken B. Utrecht. The Netherlands
10:30 – 11h: Coffee and Poster Viewing
11:00 – 12:30: Session 2: Translational Medicine in Pediatric Rheumatology
Co-chair: Nico Wulfraat Giovanni Filocamo
YIM.O.7. Evidence for persistent endothelial injury and subclinical inflammation in juvenile Dermatomyositis Krol P, Shah V, Eleftheriou D, Hong Y, Beresford M, Wedderburn L, Pilkington C, Brogan P. London.
YIM.O.8. Overexpression of CREMalpha accelerates the onset of auto-immune mediated disease in a murine model of lupus Ohl K, Lippe R, Honke N, Maschke-Neuss K, Wagner N, Tenbrock K. Aachen.
YIM.O.9. In vitro skewing of naïve human CD4+ T cells, does not result in clearly differentiated helper T cell subsets Meerding J, Vercoulen Y, Klein M, van den Ham H, de Boer R, Prakken B. Utrecht. The Netherlands
YIM.O.10. Effect of different variants of tnfrsf1a gene on health-related quality of life (HRQOL) in children Pelagatti MA, Meini A, Caorsi R, Cattalini M, Federico S, Zulian F, Calcagno G, Tommasini A, Bossi G, Martini A, Gattorno M. Genoa. Italy
YIM.O.11. Clinical Characteristics of children carrying yhe hypomorphic V198M mutation of NLRP3 gene Caorsi R, Meini A, Insalaco A, Zulian F, Lepore L, Caroli F, Finetti M, Federici S, Ceccherini I, Martini A, Gattorno M. Genoa.Italy
YIM.O.12. High frequency of subclinical synovitis, as detected by ultrasound, in juvenile idiopathic arthritis patients with clinically-defined inactive disease Magni-Manzoni S, Scirè C, Ravelli A, Klersy C, Rossi S, Muratore V, Visconti C, Lanni S, Merli P, Montecucco C. Pavia.
12:30 – 13:30h How to combine research with a career in pediatric rheumatology Virginia Pascual. Investigator Baylor Institute for Immunology Research. Dallas.
13:30 – 15:00: Lunch
15:00 – 16: 30: Session 3: Basic Science in Pediatric Rheumatology 2
Co-chair: Hermann Girschick. Associate Professor and Head of the divisions of Paediatric Rheumatology, the Children's Hospital,
Wilco de Jager
YIM.O.13. The role of Vasoactive Intestinal Peptide Receptor Type One in Pathogenesis of oligoarticular Juvenile Idiopathic Arthritis Pesenacker AM, Varsani H, Crompton T, Wedderburn LR.
YIM.O.14. Human induced CD4+CD25+FOXP3+ regulatory T cells suppress effector immune responses in vitro, but not in vivo Vercoulen Y, GuichelaarT, Meerding J, Emmelot M, Pingen M, de Jager W, Mutis T, Martens A, Coffer P, Prakken B. Utrecht, The Netherlands
YIM.O.15. Microparticle mediated thrombin generation: a novel mechanism of thrombotic propensity associated with systemic vasculitis of the young Eleftheriou D, Hong Y, Klein NJ, Brogan PA.
YIM.O.16. CD30 displays an immune regulating role on human CD4+ T Bakker MH, Vercoulen Y, Meerding J, Prakken BJ.
YIM.O.17. Impact Of Gene Mutations On Disease Severity Scores In Patients With Familial Mediterraian Fever: Preliminary Results Demirkaya E, Kalkan G, Acikel C, Peru H, Karaoglu A, Polat A, Sari E, Dursun I, Gok F, Ozen S. Ankara. Turkey
YIM.O.18. Anakinra treatment prior to steroids in newly diagnosed systemic onset JIA; Changing the biology? de Jager W, Vastert SJ, Holzinger D, Kuis W, Prakken BJ, Wulffraat NM.
16:30 – 17:00: Coffee
17:00 – 18:30: Session 4: Clinical Medicine in Pediatric Rheumatology
Co-chair: Angelo Ravelli
Erkan Dermikaya
YIM.O.19. Therapeutic approaches for the treatment of active juvenile dermatomyositis: an International Multicenter Study Hasija R, Pistorio A, Ravelli A, Demirkaya E, Khubchandani R, Guseinova D, Malattia C, de Cunto C, Graham B, Haines K, Huemer C, Kimura Y, Mangge H, Martino S, Minetti C, Nordal E, Philippet P, Salgado M, Martini A, Ruperto N. Genoa. Italy
YIM.O.20. Validation of Demirkaya E, Ozen S, Pistorio A, Galasso R, Ravelli A, Hasija R, Khubchandani R, Scarpato S, Fischbach M, Iagaru N, Pasic S, Baskin E, Dressler F, van Rossum MA, Consuegra JG, Apaz MT, Ioseliani M, Mazur-ZH, Martini A, Ruperto N, Dolezalova P. Ankara.
YIM.O.21. Preliminary definition of the remission and minimal disease activity CUT-Points for the juvenile arthritis disease activity score (JADAS) Consolaro A, Filocamo G, Lattanzi B, Solari N, Lanni S, Varnier GC, Pistorio A, Ruperto N, Martini A, Ravelli A. Genoa. Italy
YIM.O.22. An international consensus survey of the diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis Davì S, Consolaro A, Guseinova D, Martini A, Cron R, Ravelli A. Genoa. Italy
YIM.O.23. Characteristics of children with Juvenile Dermatomyositis in the Martin N, Krol P, Smith S, Wedderburn L, Pilkington C, Davidson J, JDRG.
YIM.O.24. Rheumatologic manifestations in a large cohort of patients with Chronic Granulomatous Disease Magnani A, Brosselin P, Beaute J, de Vergnes N, Suarez F, Lanternier F, Hermine O, Lortholary O, Lecuit M, Blanche S, Fischer A, Mahlaoui N. Genoa.
18:30 – 19:00: YIM awards. Close of YIM
21:00 – 23:00: YIM Dinner
YIM - LIST OF POSTER PRESENTATION
YIM.P.1. Distinctive gene expression in patients with juvenile spondyloartropathy is related to autoinflammatory diseases Frleta M, Lamot L, Borote F, Tambic Bukovac L, Harjacek M. Zagreb. Croatia
YIM.P.2. Prevalence of mutations in mefv gene in slovenian children with henöch-schonlein purpura and in apparently healthy population Kolnik M, Debeljak M, Toplak N, Avčin T. Liubliana.
YIM.P.3. Interleukin-1 targeting drugs in Familial Mediterranean Fever Meinzer U, Quartier P, Alexandra JF, Hengen V, Retornaz F, Papo T, Koné-Paut I. Paris. France
YIM.P.4. Syndrome Related Arthritis Scott C, Wouters C. Cape Town.
YIM.P.5. Neutrophils gene expression profile in systemic Juvenile Idiopathic Arthritis (SJIA) patients treated successfully with anakinra Omoyinmi E, Hamaoui R, Radziszewska A, Bryant A, Zheng D, Banerjee P, Woo P. London.
YIM.P.6. Usefulness of autoantibodies against inner ear antigens for the diagnosis Giani T, Lunardi C, Simonini G, Pascoli L, Pagnini I, Cimaz R. Florence. Italy
YIM.P.7. How frequently does etanercept induce a state of remission or near-remission of joint inflammation in children with Juvenile Idiopathic Arthritis? Solari N, Palmisani E, Davì S, Visconti C, Muratore V, Verazza S, Martini A, Ravelli A, IRCCS. Genoa. Italy
YIM.P.8. Familial Mediterranean fever and liver involvement: a case series from the French Reference Centre for Auto-inflammatory diseases Rossi L, Hentgen V, Hermeziu B,
YIM.P.9. To Explore the use of the PedsQL Subjective Questionnaire to Assess Levels of Fatigue in Children with Juvenile Dermatomyositis Hassan, A, Todd A, Nistala K, Pilkington C, Maillard SM. London.
YIM.P.10. Tuberculosis in Children with SLE from Scott C, Spittal G.
YIM.P.11. Efficacy and safety of treatment with infliximab in patients with early oligo- and polyarticular Juvenile Idiopathic Arthritis Mitenko E, Alexeeva E, Valiera S, Bzarova T, Sleptsova T, Isaeva K, Lisitsyn A, Denisova R. Moscow. Russia
YIM.P.12. Yersinia pseudotuberculosis infection disrupts the intestinal barrier and enables systemic translocation of Yersinia and bacteria from the gut flora in mice Meinzer U, Barreau R, Esmiol-Welterlin S, Jung C, Berrebi D, Dussaillant M, Bonacorsi S, Wolf-Watz H, Perroy J, Ollendorff V, Hugot JP.
YIM.P.13. Physiotherapy management of children with hypermobility: A review of an out patient self management exercise programme Bhagat S, Adkins D, Haggart E, Maillard, SM. London.
YIM.P.14. Pain, Fatigue and Bernie C, Morgan A, Mailard SM. London.
YIM.P.15. Efficacy of TNF-a inhibitor treatment of Juvenile Idiopathic Arthritis in eastern Alberdi M, Nielsen S. Rodovre.
YIM.P.16. Glucocorticoid receptor gene polymorphism and juvenile idiopathic arthritis Kostik MM, Klyushina AA, Moskalenko MV, Scheplyagina
YIM.P.17. Bone methabolic molecular markers and juvenile idiopathic arthritis Kostik MM, Moskalenko MV, Demin GS, Scheplyagina
YIM.P.18. Use of adalimumab in juvenile idiopathic arthritis-associated refractory uveitis: efficacy in ocular disease – a retrospective case series Sen ES, Mandal K, Dick AD, Ramanan AV .
YIM.P.19. Development and initial validation of the patient’s/parent’s acceptable symptom state for Juvenile Idiopathic Arthritis: A new ambitious target for disease management Filocamo G, Consolaro A, Solari N, Palmisani E, Pederzoli S, Schiappapietra B, Pistorio A, Ruperto N, Martini A, Ravelli A. Genoa. Italy
YIM.P.20. Effectiveness of Dexamethasone Iontophoresis in Temporomandibular Joint (TMJ)-Arthritis in Juvenile Idiopathic Arthritis (JIA) Mina R, Melson P, Powell S, Hinze C, Pendl J, Brent Graham T, Brunner HI.
YIM.P.21. An analysis of the costs and treatment success of etanercept in Juvenile Idiopathic Arthritis Prince FHM, de Bekker-Grob EW, Twilt M, van Rossum MAJ, Hoppenreijs EPAH, ten Cate R, Koopman-Keemink Y, Gorter S, Raat H, van Suijlekom-Smit LWA.
YIM.P.22. Long term follow-up of patients with PFAPA syndrome followed in two tertiary national referral Centers. Caorsi R, Meini A, Cattalini M, Pelagatti MA, Federici S, Finetti M, Plebani A, Martini A, Gattorno M. Genoa. Italy
YIM.P.23. Behçet's disease in the differential diagnosis of multiple sclerosis: a pediatric case Makay B, Akıncı G, Topçu Y, Hız S, Çakmakçı H, Ünsal E. Izmir.
YIM.P.24. Effects of Methotrexate (MTX) treatment on cytokine profile and gene expression in Juvenile Idiopathic Arthritis (JIA) Ursu S, Moncrieffe H, Kassoumeri L, Wedderburn LR.
YIM.P.25. Endothelial injury and repair in childhood primary angiitis of the central nervous system Eleftheriou D, Hong Y, Klein NJ, Ganesan V, Brogan PA.
YIM.P.26. The place of the interleukin-1-receptor antagonist Anakinra in the treatment of systemic-onset juvenile idiopathic arthritis (SoJIA) Swart JF, Barug D, Möhlmann M,
YIM.P.27. Anti-C1Q, anti-nucleosome and anti-dsdna antibodies in juvenile systemic lupus erythematosus patients Almeida Jesus A, Lourdes Liphaus B, Carneiro-Sampaio M, Mattei Arruda Campos L, Rosseto E, Sheinberg M, Mangueira CL, Almeida Siva C. Sao Paulo. Brazil
YIM.P.28. Safety and Immunogenicity of Influenza Vaccine (FluVac) in Patients with Juvenile Systemic Lupus Erythematosus (JSLE) Carvalho LM, Silvestre RVD, Mello WA, Ferriani VPL. Sao Paulo. Brazil
YIM.P.29. Primary Immunodeficiencies in Juvenile Systemic Lupus Erythematosus Patients Almeida Jesus A, Lourdes Liphaus B, Almeida Silva C, Coelho Andrade LE, Coutinho A, Carneiro-Sampaio M. Sao paulo. Brazil
YIM.P.30. Prospective evaluation by Nailfold Capillaroscopy (NFC) in children and adolescents with juvenile dermatomyositis Petry Piotto DG, Terreri MTRA, Len CA, Hilário, MOE. Sao Paulo. Brazil
YIM.P.31. Th17 cells that undergo plasticity to a Th1 phenotype in human autoimmune arthritis can be detected by the expression of CD161 within the inflamed joint Nistala K, Adams S, Cambrook H, Ursu S, Olivito B, de Jager W, Evans JG, Cimaz R, Bajaj-Elliott M, Wedderburn LR.
YIM.P.32. Response to Recombinant IL1Ra (Anakinra) in two Brazilian Patients with a New Autoinflammatory Syndrome: Deficiency of Interleukin-1 Receptor Antagonist (DIRA) Almeida Jesus A, Almeida Silva C, Kim P, Gadina M, Tuyet-Hang Pham, Yang B, Stone D, Sims J, Nicole Plass, Romeo Bertola D, Carneiro-Sampaio M, Goldbach-Mansky R, El-Shanti H. Sao Paulo.
YIM.P.33. Validation of the new pediatric criteria for the diagnosis of familial mediterranean fever: Data from a mixed population of 100 children from the french reference center for auto-inflammatory disorder Kondi A, Hentgen V, Piram M, Letierce A, Guillaume-Czitrom S, Kone-Paut I. Paris.
YIM.P.34. The role of damage-associated molecular pattern (DAMP) molecules in juvenile systemic lupus erythematosus (JSLE) Jelusic-Drazic M, Grcevic D, Kovacic N, Bobek D, Vidovic M, Tambic Bukovac L, Potocki K, Malcic I, Kresimir Lukic I. Zagreb.
YIM.P.35. HMGB-1, S100A12, and RAGE as biomarkers of systemic juvenile idiopathic arthritis Jelusic-Drazic M, Grcevic D, Kovacic N, Bobek D, Vidovic M, Tambic Bukovac L, Potocki K, Malcic I, Kresimir Lukic I. Zagreb.
YIM.P.36. Croatian expiriences in treatment of Juvenile Idopathic Arthritis with biological agents Lamot L, Frleta M, Tambic Bukovac L, Harjacek M. Zagreb. Croatia
YIM.P.37. Intravenous ibandronate injections for osteoporosis treatment in children with rheumatic diseases Lisitsin A, Ekaterina A, Saniya V, Bzarova T, Denisova R, Chomahidze A, Isayeva K, Chistyakova E, Anikin A. Moscow.
YIM.P.38. Decreased Pain Threshold in Juvenile Idiopathic Arthritis: A Cross-Sectional Study Leegaard A, Jeppesen JH, Thastum M, Herlin T.
YIM.P.39. Vaccinations in pediatric patients receiving DMARDs, glucocorticosteroids or biological therapy: a systematic literature review Ott de Bruin LM, Heijstek M, Bijl M, Borrow R, van der Klis F, Kone-Paut I, Fasth A, Minden K, Ravelli A, Abinun M, Pileggi G, Borte M, Wulffraat N. Utrecht. The
YIM.P.40. The Beneficial Effect Of Mesenchymal Stem Cell Therapy In Arthritis Swart JF, Rozemuller H, Hofhuis F, Prakken BJ, Kuis W, Martens AC, Wulffraat NM.
YIM.P.41. Cogan Syndrome: a rare but severe vasculitis in pediatric age Pagnini I, Zannin ME, Sari M, Simonini G, Cimaz R, Zulian F. Florence.
YIM.P.42. Ineffectiveness of tumor necrosis alpha inhibition in association with bisphosphonates for the treatment of cherubism Pagnini I, Simonini G, Mortilla M, Giani T, Pascoli L, Cimaz R. Florence. Italy
YIM.P.43. Paediatric Autoimmune Neuropsychiatric Disease Associated with Streptococcal infection (PANDAS) and movement disorders Pascoli L, Zellini F, Giani T, Simonini G, Guerrini R , Cimaz R. Florencia. Italy
YIM.P.44. Results of arthroscopy and synovial biopsy in pediatric chronic knee monoarthritis. Chikova IA, Kostik MM, Avramenko VV, Krasnogorskaya OL, Kalashnikova OV, Chasnyk VG. Saint Petersburg. Russia
YIM.P.45. Chronic Recurrent Multifocal Osteomyelitis in Children Raja RA, Nielsen SM.
YIM.P.46. Functional Status in Severe JIA: an Assessment in a Tertiary Pediatric Rheumatology Reference Centre Boiu S, Marniga E, Bader-Meunier B, Mouy R, Quartier P, Wouters C. Paris.
YIM.P.47. Efficacy of single and multiple intraarticular corticosteroid injections in children with Juvenile Idiopathic Arthritis Lanni S, Consolaro A, Lattanzi B, Hashad S, Palmisani E, Pederzoli S, Magni-Manzoni S, Bertamino M, Filocamo G, Martini A, Ravelli A. Genoa. Italy
YIM.P.48. Vaccinations in pediatric autoimmune and autoinflammatory diseases: a systematic literature review Heijstek M, Ott de Bruin L, Bijl M, Borrow R, van der Klis F, Kone-Paut I, Fasth A, Minden K, Ravelli A, Abinun M, Pileggi G, Borte M, Wulffraat N. Utrech. The
YIM.P.49. Introducing a new approach into clinical care of children with Juvenile Idiopathic Arthritis: the juvenile arthritis multidimensional assessment report (JAMAR) Schiappapietra B, Filocamo G, Lattanzi B, Pederzoli S, Dalprà S, Varnier GC, Magni-Manzoni S, Guseinova D, Ruperto N, Martini A, Ravelli A. Genoa. Italy
YIM.P.50. Combination therapy with Rituximab and Cyclophosphamide in two girls with refractory lupus nephritis Lamot L, Frleta M, Tambic Bukovac L, Harjacek M. Zagreb. Croatia
YIM.P.51. Disease Patterns in Vietnamese Children with SLE Dung N, Thoai Huynh L, Nielsen S, Pedersen FK, Zak M. Copenhagen.
YIM.P.52. Prevention of flare recurrences in childhood refractory chronic uveitis: an open-label prospective, comparative, multi-centre, cohort study of Adalimumab versus Infliximab. Simonini G, Taddio A, Cattalini M, Caputo R, De Libero C, Naviglio S, Bresci C, Lorusso M, Lepore L, Cimaz R. Florence. Italy
YIM.P.53. An atypical presentation of Kikuchi-Fujimoto Disease associated with a transient increase of lupus specific autoantibodies: Case Report and Literature Review. Belder-Preston D, Pound C, Jurencak R. Ottawa.
YIM.P.54. PFAPA syndrome: single centre experience Król P, Doležalová P. Prague. Czech Republic
YIM.P.55. Severe atipical henoch-schonlein purpura with elements of microscopic polyangitis Lazarevic D, Golubovic E, Jelena V, Tatiana S. Nis. Serbia
YIM.P.56 PFAPA syndrome and increased levels of IgD-a distinct clinical phenotype? Eleftheriou D, Ho A , Standing A, Klein NJ, Lachmann HJ, Hawkins PN, Woo P, Brogan PA.
YIM.P.57. Early functional impairment and structural changes predict long-term damage in children with polyarticular Juvenile Idiopathic Arthritis Pederzoli S, Tsitsami E, Consolaro A, Solari N, Bertamino M, Davì S, Lanni S, Magni-Manzoni S, Pistorio A, Martini A, Ravelli A. Genoa. Italy
YIM.P.58. TNF-blocking agents in Juvenile Psoriatic Arthritis: are they effective? Otten MH, Prince FHM, ten Cate R, van Rossum MAJ, Twilt M, Hoppenreijs EPAH, Koopman-Keemink Y, Oranje AP, de Waard-van der Spek FB, Gorter SL, Armbrust W, Dolman KM, Wulffraat NM, van Suijlekom-Smit LWA.
YIM.P.59. Adolescents with juvenile idiopathic arthritis currently followed in a tertiary care hospital have a better psychosocial well-being than healthy adolescents Dalprà S, Filocamo G, Solari N, Palmisani E, Bertamino M, Lanni S, Magni-Manzoni S, Schiappapietra B, Ruperto N, Martini A, Ravelli A. Genoa. Italy
YIM.P.60. Effectiveness of etanercept in children with Enthesitis Related Arthritis Otten MH, Twilt M, Prince FHM, Armbrust W, ten Cate R, Gorter SL, Koopman-Keemink Y, Swart JF, Dolman KM, Hoppenreijs EPAH, Wulffraat NM, van Rossum MAJ, van Suijlekom-Smit LWA.
YIM.P.61. Antinuclear antibody positive patients should be grouped as a separate category in the classification of Juvenile Idiopathic Arthritis Lattanzi B, Varnier GC, Dalprà S, Verazza S, Filocamo G, Magni-Manzoni S, Pistorio A, Ruperto N, Martini A, Ravelli A. Genoa. Italy
YIM.P.62. Odontostomatologic involvement in Juvenile Localized Scleroderma of the face Trainito S, Herlin T, Klit Pedersen T, Martini G, Scibetta C, Fioretti G, Favero V, Puggina S, Favero L, Zulian F. Padua.
YIM.P.63. Quality of life in patients with juvenile arthritis: Infliximab might make a difference Denisova R, Alexeeva E, Albitskiy V , Vinyarskaya I, Valieva S, Bzarova T, Lisitsin A, Gudkova E, Chomahidze A, Isayeva K. Cincinnati. USA
YIM.P.64. Different patterns of response to Anakinra treatment in Systemic onset Juvenile Idiopathic Arthritis Melo Gomes S, Al-Obaidi M, Maritsi D, Brogan P, Woo P. Lisbon. Portugal
YIM.P.65. Nutritional status related to vitamin d in children and adolescents with systemic lupus erythematosus Peracchi OAB, Hilário MOE, Terreri MT, Sarni ROS, Munekata RV, Lazaretti M. Sao Paulo. Brazil
YIM.P.66. Fibrodysplasia Ossificans Progressiva in South African Children Scott C, Urban M, Arendse R, Chinniah K, Esser M, Dandara C, Beighton P. Cape Town.
YIM.P.67. Multiple organ dysfunction syndrome in Juvenile Systemic Lupus Erythematosus patients Fiorot FJ, Silva CAA, Delgado AF, Campos LMA. Sao paulo. Brazil
YIM.P.68. Ultrasonographic Measurement of the Femoral Cartilage Thickness in Juvenile Idiopathic Arthritis Patients With Unilateral Knee Involvement Demirkaya E, Polat A, Celebi A, Ozcakar L, Akse-Onal V, Ozen S. Ankara.
YIM.P.69. Long-term follow up of Hyper IgD syndrome: a national collaborative study Federici S, Tommasini A, Meini A, Calcagno G, Zulian F, Consolini R, Finetti M, Breda L, Caorsi R, Obici L, Gallizzi R, Gigante D, Alessio M, Martín A, Gattorno M. Genoa. Italy
YIM.P.70. Validation of the newly developed pediatric criteria for the diagnosis of Familiar Mediterranean fever in a large pediatric cohort of western European children with periodic fever Federici S, Calcagno G, Finetti M, Meini A, Vitale A, Cattalini M, Caorsi R, Zulian F, Tommasini A, Baldi M, Frenkel J, Ceccherini I, Martini A, Gattorno M. Genoa.
YIM.P.71. Sensitivity and specificity of diagnostic guidelines for macrophage activation syndrome (MAS) or hemophagocytic lymphohistiocytosis in children with systemic JIA-Associated Mas Palmisani E, Guseinova D, Davì S, Dalprà S, Visconti C, Lattanzi B, De Sanctis S, Muratore V, Martini A, Ravelli A. Genoa. Italy
YIM.P.72. Efficacy of infliximab treatment in patients with early and long-standing juvenile idiopathic arthritis Sleptsova T, Alexeyeva E, Valiyeva S, Bzarova T, Chistyakova E, Denisova R, Lisicin A, Isayeva X, Mitenko E. Moscow. Russia
YIM.P.73. Wegener´s granulomatosis: clinical features and outcome in 5 Czech children Böhm M, Němcová D, Hoza J, Lád V, Šuláková T, Doležalová P. Prague. Czech Republic
YIM.P.74. Arthropathy In Nephropathic Cystinosis, An Under-Recognised Disorder? Cruikshank M ,Ramage I , Irwin G , Galea P ,
YIM.P.75. Anakinra for the treatment of TNF receptor associated periodic syndrome Melo Gomes S, Loeffler J, Rowczenio D, Trojer H, Russell T, Drewe E, McDermott E, Rannigan L, Lane T, Woo P, Brogan P, Hawkins PN, Lachmann HJ.
Young Investigators Meeting One of the aims of PRES is to stimulate research in the field of Paediatric Rheumatology. One way of doing this is to enable young investigators to increase their skills in reputable laboratories and clinical research groups in Europe and to provide a platform for the exchange of their experiences. The 2010 Young Investigators meeting will be held from 9.00 hrs – 20.00 hors on Wednesday 8th September. There are 100 vacancies for this year PRES meeting.
Qualifying criteria for a free place To qualify for a free place you must:
To apply for PRES membership please contact the society via www.pres.org.uk Free registration for Young Investigators attending includes:
*** Available only for Young Investigators
YIM Dinner - Wednesday 8th September Main Meeting Bursaries for YIM attendees:
|
